DEC 23, 2015 8:02 AM PST

Immune Cell Regulation to Treat Prostate Cancer

WRITTEN BY: Kara Marker
Inhibiting large cellular populations of myeloid derived suppressor cells (MDSCs) could be a new therapy for prostate cancer, results show from a study at the University of Texas MD Anderson Cancer Center.

Upon infection by a pathogen or cancerous cells, MDSCs expand and suppress the T cell response needed by the body to properly fight cancer growth. Reversing this process might be the key to treating prostate cancer.
 

"MDSCs are infiltrating immune cells that promote tumors through their striking lack of immunological response,” said Y. Alan Wang, PhD and co-author of the study paper recently published in Cancer Discovery.

At first glance it seems that the T cell-inhibiting action of MDSCs is counterintuitive, but this action does come in handy when the body is regulating “immune response and tissue repair” in healthy individuals (Nature Reviews Immunology).

Using a unique prostate cancer mouse model and patient tumor samples, scientists from the University of Texas depleted MDSCs in the models and observed the subsequent response of the tumors. After seeing progression suppressed, the team was also able to identify a regulatory pathway involving Hippo-Yap1 and Cxcl5, a chemokine that attracts MDSCs which then express anther protein, Cxcr2. Because of its association with MDSCs, blocking Cxcr2 similarly suppressed tumor progression to when MDSCs are directly suppressed.

The same result also occurred when Yap1 expression was inhibited. As a regulator of Cxcl5, Yap1 is unable to recruit MDSCs to the tumor site when inhibited.

"The targeting of either MDSC recruitment or infiltrated MDSCs may represent a valid therapeutic opportunity in treating advanced prostate cancer." Said Ronald A. DePinho, MD, and the other co-author on the paper.

Watch the following video to learn more about prostate cancer.

Source: University of Texas MD Cancer Center 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 17, 2020
Immunology
Nervous Protein Neuromedin B May Prevent Immune Reactivity
AUG 17, 2020
Nervous Protein Neuromedin B May Prevent Immune Reactivity
A protein produced by the nervous system seems to play a role in regulating the immune system. For people with inflammat ...
AUG 21, 2020
Microbiology
Vaccine Aimed at Fungi May Also Protect Against MRSA
AUG 21, 2020
Vaccine Aimed at Fungi May Also Protect Against MRSA
Staphylococcus aureus is a common bacterium. If it stays on the skin it's harmless, but if it gets into the bloodstream, ...
SEP 06, 2020
Microbiology
Small Changes in Vaccine Molecules Could Make Them More Effective
SEP 06, 2020
Small Changes in Vaccine Molecules Could Make Them More Effective
Effective vaccines have to trigger an immune response, which is intended to create an immune 'memory' of a specific infe ...
SEP 07, 2020
Immunology
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
SEP 07, 2020
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
The ability to edit the human genome using CRISPR has been heralded as a revolution in medicine. However, one of the big ...
SEP 11, 2020
Immunology
Could a Drug for Cats Treat COVID?
SEP 11, 2020
Could a Drug for Cats Treat COVID?
Canadian researchers have discovered that a drug used to treat coronavirus infections in cats shows promise in helping C ...
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
Loading Comments...